Asensus Surgical, Inc. (ASXC)
Aug 22, 2024 - ASXC was delisted (reason: acquired by KARL STORZ)
0.350
0.00 (0.00%)
Inactive · Last trade price on Aug 21, 2024

Company Description

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia.

It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.

The company’s products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue.

The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021.

Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Asensus Surgical, Inc.
Asensus Surgical logo
Country United States
Founded 2006
Industry Medical Devices
Sector Healthcare
Employees 209
CEO Anthony Fernando

Contact Details

Address:
1 TW Alexander Drive, Suite 160
Durham, North Carolina 27703
Phone 919 765 8400
Website asensus.com

Stock Details

Ticker Symbol ASXC
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000876378
CUSIP Number 04367G103
ISIN Number US04367G1031
Employer ID 11-2962080
SIC Code 3841

Key Executives

Name Position
Anthony Fernando President, Chief Executive Officer and Director
Shameze Rampertab B.Sc. MBA, CA, CPA Executive Vice President and Chief Financial Officer
Joshua B. Weingard Chief Legal Officer and Secretary
Ethan Loiselle Vice President of Global Marketing
Ravi Kommineni Head of Global Quality and Regulatory
Motti Frimer Vice President of Research & Development, Digital Solutions and MD of Asensus Surgical

Latest SEC Filings

Date Type Title
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 22, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments